Therapeutics Ovulation Agents

Ovulation induction

March CM

Published May 1993 The Journal of Reproductive Medicine, 38(5), 335-346

Abstract

Induction of ovulation is indicated for anovulatory and amenorrheic women as well as for women who have an inadequate luteal phase. It is also indicated as a strategy for recruiting multiple follicles for women with unexplained infertility and those who are undergoing assisted reproductive technologies. The use of various agents and detection of ovulation are described. This includes a discussion of clomiphene citrate, bromocriptine, human menopausal gonadotropins, urinary follicle stimulating hormone and pulsatile gonadotropin releasing hormone therapy. Regimens, success rates and potential complications of each form of therapy are reviewed. Also discussed is the use of combination therapy and partial ovarian destruction.

Topics

By this author

Related research

Therapeutics › Ovulation Agents › Selective Estrogen Receptor Modulators · Infertility › Ovulation Induction › Gonadotropin Therapy · Menstrual Cycle › Cycle Disorders › Ovulatory Disturbances
March et al. 1993, March 1993